Precision medicine in regulatory decision making: Biomarkers used for patient selection in European Public Assessment Reports from 2018 to 2020
精准医疗在监管决策中的应用：2018年至2020年欧洲公共评估报告中用于患者选择的生物标志物
期刊:Cts-Clinical and Translational Science
影响因子:2.8
doi:10.1111/cts.13641
Bakker, Elisabeth; Starokozhko, Viktoriia; Kraaijvanger, Jet W M; Heerspink, Hiddo J L; Mol, Peter G M
